Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report

BACKGROUND: The understanding of coronavirus disease 2019 (COVID-19) is rapidly evolving. Although it is primarily a respiratory illness, other manifestations, such as Guillain-Barré syndrome, immune thrombocytopenia, and immune-mediated thrombotic thrombocytopenic purpura, have been described. We p...

Descripción completa

Detalles Bibliográficos
Autores principales: Tholin, Birgitte, Hauge, Marit Teigen, Aukrust, Pål, Fehrle, Lutz, Tvedt, Tor Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556888/
https://www.ncbi.nlm.nih.gov/pubmed/33054818
http://dx.doi.org/10.1186/s13256-020-02503-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556888/
https://www.ncbi.nlm.nih.gov/pubmed/33054818
http://dx.doi.org/10.1186/s13256-020-02503-9

Ejemplares similares